1. Home
  2. EVTL vs ENTX Comparison

EVTL vs ENTX Comparison

Compare EVTL & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$3.73

Market Cap

607.7M

Sector

Industrials

ML Signal

HOLD

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.20

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
ENTX
Founded
2016
2010
Country
United Kingdom
Israel
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
607.7M
74.7M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
EVTL
ENTX
Price
$3.73
$1.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$13.20
$10.00
AVG Volume (30 Days)
688.5K
95.5K
Earning Date
03-24-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.18
Revenue
N/A
$181,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$7.44
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$1.00
52 Week High
$7.60
$3.22

Technical Indicators

Market Signals
Indicator
EVTL
ENTX
Relative Strength Index (RSI) 35.63 40.33
Support Level $3.71 $1.17
Resistance Level $4.70 $1.61
Average True Range (ATR) 0.22 0.15
MACD 0.00 -0.00
Stochastic Oscillator 23.38 18.47

Price Performance

Historical Comparison
EVTL
ENTX

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: